Skip to content
Trial Eligibility
Menu

Sickle Cell Kidney Biorepository

NCT07064174

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Kidney disease is a major cause of illness and death in people with sickle cell disease and sickle cell trait. Despite these concerning facts, we do not (1) have an in-depth understanding of how kidney disease starts in sickle cell disease and sickle cell trait, (2) have detailed insights into why kidney disease is worse in people with sickle cell disease and sickle cell trait, (3) have management options that are tailored to treating or preventing kidney disease in people with sickle cell disease or sickle cell trait.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Sickle Cell Trait
  • Sickle Cell Disease (SCD)
  • Chronic Kidney Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Texas Southwestern Medical Center
Last updated on ClinicalTrials.gov
April 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 2

  • Parkland Memorial Hospital · Dallas, TX
  • University of Texas Southwestern Medical Center · Dallas, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.